Crowdonomics
WatchlistPortfolio
This isn’t 20/20 GeneSystems’s most recent raise. Reg CF · Convertible Note · Oct 2025 (Closed) is more current.View latest round
20/20 GeneSystems

Reg CF · Preferred Stock · May 2024

ClosedReached targetReg CFPreferred Equity
via WeFunderView campaign
Raised
$556.7K / $5M max
11% of ceiling · target hit day 3
Investors
406
$1.4K avg
Post-money valuation
$70.4M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$557K$278K$0
4062030
May 6, 2024 · openedFeb 15, 2025 · last reading
Target ($50K) hit — May 9, 2024, day 3Deadline Apr 30, 2025 — 74 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$11.1M
$2.2M
FY2022
$1.4M
−$6.4M
FY2023
RevenueNet income
Metric
FY2022 audited
FY2023 audited
Income statement
Revenue
$11,059,145
$1,424,304
Cost of goods sold
$5,937,398
$1,315,166
Gross margin
46%
8%
Net income
$2,186,875
-$6,391,309
Taxes paid
$0
$0
Balance sheet
Cash
$8,807,575
$4,089,461
Accounts receivable
$764,924
$68,834
Total assets
$12,215,021
$6,367,828
Short-term debt
$0
$0
Long-term debt
$207,246
$229,164
Total liabilities
$2,840,755
$2,080,336
Other
Headcount
30
21

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$69.9M
Post-money$70.4M
Price / share$5.34
Shares offered9,364

Offering details

Target$50,000
Max$5,000,000
Min investment$500
OpenedMay 6, 2024
DeadlineApr 30, 2025
ClosedApr 30, 2025
Days active359

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-24-000551

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.